Balyasny Asset Management LLC Revance Therapeutics, Inc. Put Options Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
Put Options
1 transactions
Others Institutions Holding RVNC
# of Institutions
102Shares Held
44.7MCall Options Held
2.05MPut Options Held
5.47M-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA5.94MShares$15.3 Million9.37% of portfolio
-
Alliancebernstein L.P. New York, NY3.5MShares$8.99 Million0.0% of portfolio
-
Glazer Capital, LLC New York, NY1.95MShares$5.01 Million0.4% of portfolio
-
Newtyn Management, LLC New York, NY1.81MShares$4.65 Million0.95% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...